Literature DB >> 28786079

JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia 1. Acute myeloid leukemia (AML).

Shuichi Miyawaki1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28786079     DOI: 10.1007/s12185-017-2303-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  7 in total

1.  Refinement of the Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.

Authors:  Yasuhiko Shibasaki; Tatsuya Suwabe; Takayuki Katagiri; Tomoyuki Tanaka; Takashi Ushiki; Kyoko Fuse; Naoko Sato; Toshio Yano; Takashi Kuroha; Shigeo Hashimoto; Miwako Narita; Tatsuo Furukawa; Hirohito Sone; Masayoshi Masuko
Journal:  Int J Hematol       Date:  2018-05-09       Impact factor: 2.490

2.  Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia.

Authors:  Nanami Gotoh; Takayuki Saitoh; Noriyuki Takahashi; Tetsuhiro Kasamatsu; Yusuke Minato; Alkebsi Lobna; Tsukasa Oda; Takumi Hoshino; Toru Sakura; Hiroaki Shimizu; Makiko Takizawa; Hiroshi Handa; Akihiko Yokohama; Norifumi Tsukamoto; Hirokazu Murakami
Journal:  Int J Hematol       Date:  2018-05-08       Impact factor: 2.490

Review 3.  Hematopoietic stem cell transplantation for acute myeloid leukemia.

Authors:  Akiyoshi Takami
Journal:  Int J Hematol       Date:  2018-01-27       Impact factor: 2.490

4.  Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).

Authors:  Akihiro Abe; Yukiya Yamamoto; Akira Katsumi; Akinao Okamoto; Masutaka Tokuda; Yoko Inaguma; Kiyoko Yamamoto; Masamitsu Yanada; Tadaharu Kanie; Akihiro Tomita; Yoshiki Akatsuka; Masataka Okamoto; Toshiki Kameyama; Akila Mayeda; Nobuhiko Emi
Journal:  Int J Hematol       Date:  2017-12-20       Impact factor: 2.490

5.  Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission.

Authors:  Toshihiro Miyamoto; Koji Nagafuji; Tomoaki Fujisaki; Naoyuki Uchida; Kosei Matsue; Hideho Henzan; Ryosuke Ogawa; Ken Takase; Takatoshi Aoki; Michihiro Hidaka; Takanori Teshima; Shuichi Taniguchi; Koichi Akashi; Mine Harada
Journal:  Int J Hematol       Date:  2017-12-14       Impact factor: 2.490

6.  Treatment patterns and healthcare resource utilization in patients with FLT3-mutated and wild-type acute myeloid leukemia: A medical chart study.

Authors:  James D Griffin; Hongbo Yang; Yan Song; David Kinrich; Manasee V Shah; Cat N Bui
Journal:  Eur J Haematol       Date:  2019-02-05       Impact factor: 2.997

7.  Development and Effects of Leukemia Nursing Simulation Based on Clinical Reasoning.

Authors:  Aeri Jang; Miok Song; Suhyun Kim
Journal:  Int J Environ Res Public Health       Date:  2021-04-15       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.